[9-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-PURIN-6-YL]-[(4-TRIFLUOROMETHYL)-PHENYL]-METHANOL
Compound with spectra: 1 NMR
![[9-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-PURIN-6-YL]-[(4-TRIFLUOROMETHYL)-PHENYL]-METHANOL](/api/compound/1EKL9Y31fmn.png?ph=true&h=300&w=458 "[9-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-PURIN-6-YL]-[(4-TRIFLUOROMETHYL)-PHENYL]-METHANOL")
| SpectraBase Compound ID | 1EKL9Y31fmn |
|---|---|
| InChI | InChI=1S/2C24H23F3N4O8/c2*1-11(32)36-8-16-20(37-12(2)33)21(38-13(3)34)23(39-16)31-10-30-18-17(28-9-29-22(18)31)19(35)14-4-6-15(7-5-14)24(25,26)27/h2*4-7,9-10,16,19-21,23,35H,8H2,1-3H3/t2*16-,19?,20-,21-,23-/m00/s1 |
| InChIKey | AVNWPSZTXBOYGC-FMPZRJGLSA-N |
| Mol Weight | 1104.93 g/mol |
| Molecular Formula | C48H46F6N8O16 |
| Exact Mass | 1104.293596 g/mol |
| Enantiomer InChIKey | AVNWPSZTXBOYGC-JREGZTQZSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
9H-Purine, 6-(5-methyl-2-furanyl)-9-(2,3,5-tri-O-acetyl-.beta.-D-ribofuranosyl)-
2',3',5'-TRI-O-ACETYLADENOSINE-6-N-[O,O-DIETHYL-PHOSPHORAMIDATE]
2',3',5'-TRI-O-ACETYLADENOSINE-6-N-[O,O-DIETHYL-PHOSPHOROTHIOAMIDATE]
(2R,3R,4R,5R)-2-(6-(2-acetoxybenzylamino)-9H-purin-9-yl)-5-(acetoxymethyl)tetrahydrofuran-3,4-diyl diacetate
9-(2,3,5-tri-O-acetyl-.beta.-D-ribofuranosyl)-N6-(p-toluenesulfonyl)adenine
2-Amino-6-acetamidomethyl-9-(1,3,5-tri-O-acetyl-.beta.,D-ribofuranosyl)purine
[6-(15)-NH2]-2',3',5'-TRI-O-ACETYL-N-(6)-BENZOYLADENOSINE
[(2R,3R,4R,5R)-3,4-diacetoxy-5-[6-[deuterio-(4,4-dideuterio-4-acetoxy-3-methyl-butyl)amino]purin-9-yl]tetrahydrofuran-2-yl]methyl acetate
2',3',5'-TRIS-O-(PHENOXYACETYL)-ADENOSINE-6-N-[O,O-DIETHYL-PHOSPHORAMIDATE]
(2R,3R,4R,5R)-2-(6-(3-acetoxybenzylamino)-9H-purin-9-yl)-5-(acetoxymethyl)tetrahydrofuran-3,4-diyl diacetate
| Title | Journal or Book | Year |
|---|---|---|
| 6-Magnesiated Purines: Preparation and Reaction with Aldehydes | Organic Letters | 2003 |